Welcome to our dedicated page for JBT MAREL SEC filings (Ticker: JBTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
JBT Marel Corporation filings document the company's food and beverage technology business, public-company governance and capital structure. Form 8-K reports furnish quarterly and full-year results, guidance materials, Regulation FD investor presentations, segment realignment disclosures and other material corporate events tied to its Protein Solutions and Prepared Food and Beverage Solutions operations.
The company's SEC record also includes proxy disclosures on board matters, executive compensation and annual meeting governance. Capital-structure filings describe common stock and convertible senior notes due 2030, including related indenture, hedge and warrant arrangements, while officer-transition disclosures record changes in financial reporting responsibilities.
Gudmundsson Olafur S reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp director Olafur S. Gudmundsson reported an equity award consisting of 1,232 restricted stock units (RSUs). These RSUs will settle one-for-one in shares of Common Stock on June 1, 2027, subject to his continued service through that date.
After this award, he holds 11,212 shares of Common Stock directly. The filing also reports additional Common Stock held indirectly through Noruz ehf and related entities, where Gudmundsson’s economic interest is limited and large portions are held for the benefit of his spouse and children.
JBT MAREL Corp director Svafa Gronfeldt received a stock-based compensation award. On June 1, 2026, the director was granted 1,232 shares of Common Stock at a price of $0.0000 per share, increasing direct ownership to 3,132 shares.
The footnote explains this grant is in the form of restricted stock units (RSUs) that will settle one-for-one in shares of Common Stock on June 1, 2027, subject to the director’s continued service through that date. This is a non-market, compensation-related acquisition rather than an open-market purchase.
FELDMAN ALAN D reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp director Alan D. Feldman reported an equity award of 1,232 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs will settle one-for-one into Common Stock on June 1, 2027, as long as he continues serving through that date.
Following this grant, Feldman directly holds a total of 65,855 shares of JBT MAREL Corp Common Stock. This award reflects stock-based compensation rather than an open-market purchase.
BRASIER BARBARA L reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp director Barbara L. Brasier received a grant of 1,232 restricted stock units (RSUs) of Common Stock. The award was made at a stated price of $0.00 per share as equity compensation and increases her direct holdings to 10,259 shares.
The footnote explains that these RSUs will settle one-for-one into shares of Common Stock on June 1, 2027, provided she continues to serve with the company through that date. This is a compensation-related equity award rather than an open-market stock purchase.
JBT Marel Corporation reported the results of its annual meeting of stockholders. A total of 46,668,495 shares of common stock were represented, constituting a quorum. Stockholders elected ten directors to serve until the 2027 annual meeting, with each nominee receiving substantially more votes "for" than "against."
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers, with 42,078,943 votes for, 3,116,022 against, and 332,884 abstentions, plus 1,140,646 broker non-votes. In addition, they ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026, with 46,589,275 votes for, 25,979 against, and 53,241 abstentions.
JBT Marel Corp ownership disclosure: T. Rowe Price Associates, Inc. reports beneficial ownership of 2,750,884 shares of Common Stock, representing 5.3% as of 03/31/2026. The filing shows sole voting power over 2,736,029 shares and sole dispositive power over 2,750,884 shares. The submission is signed by Ellen York, Vice President, on 05/15/2026. The filer includes a statement denying beneficial ownership in the text.
JBT Marel Corporation filed an amended report to correct the start date of its previously announced share repurchase program. The program, authorized for up to $200 million of common stock, will now run from May 18, 2026 through May 31, 2029.
The company also declared a quarterly cash dividend of $0.10 per share of common stock, payable on June 9, 2026 to stockholders of record as of May 26, 2026. A press release detailing the corrected effective date and these capital return actions is included as an exhibit.
JBT Marel Corporation announced that its board has declared a quarterly cash dividend of $0.10 per share of outstanding common stock. The dividend will be paid on June 9, 2026, to stockholders of record as of May 26, 2026.
The board also authorized a new share repurchase program for up to $200 million of the company’s common stock, effective from June 1, 2026 through May 31, 2029. Repurchased shares will become treasury stock, and the company can modify, suspend, or discontinue the program at its discretion.
JBT Marel Corporation reported a sharp turnaround for the three months ended March 31, 2026, with revenue of $936 million, up 9.6% from 2025, and net income of $45 million versus a prior-year loss of $173 million. Gross margin improved to 35.1% as synergy benefits and higher volumes more than offset higher tariff costs.
Selling, general and administrative expenses fell significantly, aided by the JBT Marel 2025 Integration restructuring plan and lower M&A costs. Adjusted EBITDA rose to $142 million with a 15.2% margin. Operating cash flow strengthened to $119 million, and free cash flow reached $100 million. Total debt stood at $1.84 billion, including convertible notes maturing in 2026 and 2030, while cash and cash equivalents were $211 million.
JBT Marel Corporation reported strong first quarter 2026 results and reiterated its full-year 2026 outlook. Revenue rose 10% to $936 million, with orders above $1 billion and a book-to-bill ratio of 1.14x. Net income was $45 million, reversing a $173 million loss a year earlier, and diluted EPS was $0.86 versus a $3.35 loss. Adjusted EPS increased to $1.58 from $0.97, and adjusted EBITDA grew to $142 million, a 15.2% margin. Free cash flow reached $100 million, reducing net debt to trailing twelve months adjusted EBITDA to 2.6x. Protein Solutions drove growth with 22% higher revenue and a 21.7% adjusted EBITDA margin, while Prepared Food and Beverage Solutions revenue was flat and margin softened. For full year 2026, the company continues to guide revenue of $3.99–$4.07 billion, net income margin of 6.1%–6.6%, adjusted EBITDA margin of 17.0%–17.5%, GAAP diluted EPS of $4.70–$5.15, and adjusted EPS of $8.00–$8.50, including anticipated restructuring, M&A, and acquisition-related amortization costs.